Lineus Medical Completes UK Registration for SafeBreak® Vascular
illi News/10322656

FAYETTEVILLE, Ark. - illiNews -- Lineus Medical is now officially registered in the United Kingdom, enabling the company to begin distributing SafeBreak® Vascular within the UK healthcare market. UK registration represents an important step in Lineus Medical's international expansion strategy, further extending access to SafeBreak Vascular for hospitals and clinicians on a global scale. With regulatory requirements in place, Lineus Medical can now work with distribution partners to bring its breakaway IV technology to the UK.

SafeBreak Vascular is a breakaway device for IV lines clinically proven to reduce IV complications.¹ When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When separation occurs, valves on both ends of the device close to prevent medication spills from the pump and blood loss from the patient. Patients avoid additional needlesticks, nurses save time, and hospitals save money.¹

More on illi News

• Litera's Agentic AI Drives 10x User Growth in 3 Months since Launching
• Breakout Phase for Public Company: New Partnerships, Zero Debt, and $20 Million Growth Capital Position Company for 2026 Acceleration
• Japan's Patented "Hammock'n" Smartphone Band Targets Hand Fatigue From Long Phone Use
• Reditus Group Introduces A New Empirical Model for Early-Stage B2B Growth
• CCHR: Harvard Review Exposes Institutional Corruption in Global Mental Health

"Completing UK registration is another meaningful milestone as we continue to expand access to SafeBreak globally," said Vance Clement, CEO of Lineus Medical. "Each new market brings us closer to our mission of removing the pains associated with IV lines and improving patient safety across healthcare systems worldwide. UK registration allows SafeBreak to reach another 69 million people."

"This registration allows us to move forward with distribution planning in the UK and supports our broader international commercialization efforts," said Larry Hayes, Chief Commercial Officer of Lineus Medical. "We are focused on working with the right partners to ensure SafeBreak Vascular is accessible to clinicians who are looking to reduce IV complications and improve care at the bedside."

About Lineus Medical:
Lineus Medical is the developer of SafeBreak® Vascular, a breakaway technology proven to reduce IV restarts and IV complications.¹ Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn, Facebook, and Instagram.

References

1. Data on file.